DE3911263A1 - Kombinationspraeparate - Google Patents

Kombinationspraeparate

Info

Publication number
DE3911263A1
DE3911263A1 DE3911263A DE3911263A DE3911263A1 DE 3911263 A1 DE3911263 A1 DE 3911263A1 DE 3911263 A DE3911263 A DE 3911263A DE 3911263 A DE3911263 A DE 3911263A DE 3911263 A1 DE3911263 A1 DE 3911263A1
Authority
DE
Germany
Prior art keywords
treatment
combination
preparations according
therapy
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE3911263A
Other languages
German (de)
English (en)
Other versions
DE3911263C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
Enno Prof Dr Dr Freerksen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FATOL ARZNEIMITTEL GMBH, 6685 SCHIFFWEILER, DE
Original Assignee
Saarstickstoff-Fatol GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saarstickstoff-Fatol GmbH filed Critical Saarstickstoff-Fatol GmbH
Priority to DE3911263A priority Critical patent/DE3911263A1/de
Priority to DE3943551A priority patent/DE3943551A1/de
Publication of DE3911263A1 publication Critical patent/DE3911263A1/de
Application granted granted Critical
Publication of DE3911263C2 publication Critical patent/DE3911263C2/de
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE3911263A 1989-04-07 1989-04-07 Kombinationspraeparate Granted DE3911263A1 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE3911263A DE3911263A1 (de) 1989-04-07 1989-04-07 Kombinationspraeparate
DE3943551A DE3943551A1 (de) 1989-04-07 1989-04-07 Kombinationspraeparate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3911263A DE3911263A1 (de) 1989-04-07 1989-04-07 Kombinationspraeparate

Publications (2)

Publication Number Publication Date
DE3911263A1 true DE3911263A1 (de) 1990-10-11
DE3911263C2 DE3911263C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1992-03-12

Family

ID=6378061

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3911263A Granted DE3911263A1 (de) 1989-04-07 1989-04-07 Kombinationspraeparate

Country Status (1)

Country Link
DE (1) DE3911263A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2185170C1 (ru) * 2001-01-29 2002-07-20 Уральский научно-исследовательский институт фтизиопульмонологии Туберкулостатическое средство
US8987304B2 (en) 2005-10-05 2015-03-24 Otsuka Pharmaceutical Co., Ltd. Antituberculous composition comprising oxazole compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HELWIG: Moderne Arzneimittel, 6. Aufl., 1988, S. 6-101, 102, 6-124, 125, 126, 6-128 bis 130 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2185170C1 (ru) * 2001-01-29 2002-07-20 Уральский научно-исследовательский институт фтизиопульмонологии Туберкулостатическое средство
US8987304B2 (en) 2005-10-05 2015-03-24 Otsuka Pharmaceutical Co., Ltd. Antituberculous composition comprising oxazole compounds

Also Published As

Publication number Publication date
DE3911263C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1992-03-12

Similar Documents

Publication Publication Date Title
DE69328967T2 (de) Synergistische kombination einer substanz mit hemmwirkung auf die magensäuresekretion und eines säureinstabilen antibiotikums
DE69518729T2 (de) Stickstoffoxyd abgebendes präparat zur behandlung von analen erkrankungen
DE2832204A1 (de) Mittel zur behandlung von nervenerkrankungen, verfahren zu seiner herstellung und seine verwendung
DE19737348C2 (de) Neue Clindamycin und Clotrimazol enthaltende pharmazeutische Zusammensetzung
DE69919868T2 (de) Oregano zur behandlung interner parasiten und protozoen
DE69420776T2 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
DE3750235T2 (de) Behandlung von autoimmunen Krankheiten mit Immunoverstärkungssubstanzen.
DE3916417C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE3726864A1 (de) Verwendung von ginkgo bilobae extrakten zur bekaempfung von entzuendlichen prozessen
DE3911263C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE19726871C1 (de) Synergistisch wirkende Zusammensetzungen zur selektiven Bekämpfung von Tumorgewebe
DE3226178A1 (de) Mittel enthaltend n-acetyl-p-aminophenol und ein antacidum
DE3943551A1 (de) Kombinationspraeparate
DE69005909T2 (de) Mischung von Vitamin A in physiologischer Dosis und verschiedenen Wirkstoffen mit therapeutischer Wirksamkeit.
DE19823319A1 (de) Topisch anwendbares Arzneimittel zur Behandlung von Virusinfektionen
DD300508A5 (de) Verfahren zur Herstellung eines pharmazentischen präparates
EP0820771A2 (de) Arzneimittel zur Behandlung von Neuropathien, das ein lipidlösliches Thiamin und eine Magnesiumverbindung enthält
DE2720420A1 (de) Wirkstoffkombination gegen sonnenerythem und diese enthaltendes arzneimittel
DE69132145T2 (de) Peritoneal wirksame medikamente
EP0268680A1 (de) Antitumorfilm aus biologisch abbaubaren polymeren
DE2340515C3 (de) Oral applizierbares Präparat für die Behandlung der Mykobakteriosen Lepra und Tuberkulose
DE3142590A1 (de) Verwendung von biotin zur behandlung der zuckerkrankheit
EP1528922A1 (de) Verwendung von treosulfan und derivaten davon zur behandlung der multiplen sklerose
DE69009538T2 (de) In der Therapeutik anwendbare Zusammensetzung mit aggregationshemmender Wirkung auf Blutplättchen.
DE2340515A1 (de) Kombinationspraeparat fuer die behandlung von mykobakteriosen

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
AH Division in

Ref country code: DE

Ref document number: 3943551

Format of ref document f/p: P

D2 Grant after examination
AH Division in

Ref country code: DE

Ref document number: 3943551

Format of ref document f/p: P

8364 No opposition during term of opposition
AH Division in

Ref country code: DE

Ref document number: 3943551

Format of ref document f/p: P

8327 Change in the person/name/address of the patent owner

Owner name: FATOL ARZNEIMITTEL GMBH, 6685 SCHIFFWEILER, DE

8339 Ceased/non-payment of the annual fee